B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silo Pharma, Inc. - Common Stock (NQ:SILO)

4.700 -0.160 (-3.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,123
Open 4.800
Bid (Size) 4.650 (100)
Ask (Size) 5.000 (1,500)
Prev. Close 4.860
Today's Range 4.500 - 4.800
52wk Range 3.315 - 15.15
Shares Outstanding 98,671,970
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Subsidiary QwikAgents Joins AMD AI Developer Program
Via Investor Brand Network
Topics Artificial Intelligence

Performance

YTD
-6.6%
-6.6%
1 Month
-21.9%
-21.9%
3 Month
-53.0%
-53.0%
6 Month
-13.3%
-13.3%
1 Year
-49.3%
-49.3%

More News

Read More
News headline image
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
From Silo Pharma, Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-07-10: top gainers and losers in today's session. ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
The market is filled with gapping stocks in Friday's session. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
From Silo Pharma, Inc.
Via GlobeNewswire
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
From Silo Pharma, Inc.
Via GlobeNewswire
NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Via Investor Brand Network
News headline image
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Silo Pharma, Inc.
Via GlobeNewswire
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Launches Ibogaine-Based TBI Therapeutics Initiative
Via Investor Brand Network
Topics Intellectual Property
News headline image
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
From Silo Pharma, Inc.
Via GlobeNewswire
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Highlights Federal Momentum Advancing Psychedelic Therapeutics Development
Via Investor Brand Network
News headline image
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
From Silo Pharma, Inc.
Via GlobeNewswire
Top movers in Thursday's session ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Into AI With Qwikagents Asset Acquisition
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
From Silo Pharma, Inc.
Via GlobeNewswire
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
From Silo Pharma, Inc.
Via GlobeNewswire
Wondering what's happening in today's after-hours session? ↗
Via Chartmill

Frequently Asked Questions

Is Silo Pharma, Inc. - Common Stock publicly traded?
Yes, Silo Pharma, Inc. - Common Stock is publicly traded.
What exchange does Silo Pharma, Inc. - Common Stock trade on?
Silo Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Silo Pharma, Inc. - Common Stock?
The ticker symbol for Silo Pharma, Inc. - Common Stock is SILO on the Nasdaq Stock Market
What is the current price of Silo Pharma, Inc. - Common Stock?
The current price of Silo Pharma, Inc. - Common Stock is 4.700
When was Silo Pharma, Inc. - Common Stock last traded?
The last trade of Silo Pharma, Inc. - Common Stock was at 07/20/26 04:00 PM ET
What is the market capitalization of Silo Pharma, Inc. - Common Stock?
The market capitalization of Silo Pharma, Inc. - Common Stock is 463.76M
How many shares of Silo Pharma, Inc. - Common Stock are outstanding?
Silo Pharma, Inc. - Common Stock has 464M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.